Estrogen Treatment Prevents Gray Matter Atrophy in Experimental Autoimmune Encephalomyelitis

Gray matter atrophy is an important correlate to clinical disability in multiple sclerosis (MS) and many treatment trials include atrophy as an outcome measure. Atrophy has been shown to occur in experimental autoimmune encephalomyelitis (EAE), the most commonly used animal model of MS. While the cl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: MacKenzie-Graham, Allan J., Rinek, Gilda A., Avedisian, Andrea, Morales, Laurie B., Umeda, Elizabeth, Boulat, Benoit, Jacobs, Russell E., Toga, Arthur W., Voskuhl, Rhonda R.
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3350614/
https://ncbi.nlm.nih.gov/pubmed/22411609
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jnr.23019
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars